Cargando…
Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives
Glioblastoma is the most lethal intracranial primary malignancy by no optimal treatment option. Cancer immunotherapy has achieved remarkable survival benefits against various advanced tumors, such as melanoma and non-small-cell lung cancer, thus triggering great interest as a new therapeutic strateg...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565291/ https://www.ncbi.nlm.nih.gov/pubmed/32824974 http://dx.doi.org/10.3390/cancers12092334 |